this morning we got results from keycorp, participaent of keyban.rnings on slightly weaker than expected revenue. put up stronger than anticipated loan growth at 5.5%. response to the news muted, stock lost 7 cents, closed at $11.6 1. i thought there are positives buried in the quarter. got to look for them, though. for example, key expect to resume their buyback program once they finalize the recent acquisition of first niagara and boosted its dividend by 13% during the last quarter. it's got a yield nearly 3%. that's a heck of a lot bet than treasuries. so it's at a nice discount. let's take a closer look with beth mooney, chairman and ceo of keycorp. welcome back to "mad money." >> thanks, jim. good to be back. >> beth, i feel like that ten days from now, we're going to be talking about an entirely different bank, you're going to finalize the first niagara. tell our viewers what the new company will look like, how big it's going to be, and how much savings you can wrings out of these acquisition once you get through it. >> jim, we're really excit

gusty winds developing along the coastline that will carry with the low clouds and the fall will keycorpch is generally in the '60s and '70s if several wildfires raging and the california the encouraging news however that is coming from the fire lines. coming from the fire lines. coming from the fire lines. hey guys lunch is here! it's on me fellas. with the chase mobile app, stephen curry can send money to more people in less time. thanks, steph! no problem. even to friends in a growing number of other banks. ya'll ready to go? come on fellas let's go! easy to use chase technology for whatever you're trying to master. >>haaziq madyun: about the zero previous sexual misconduct investigation this to the minister's office is looking for that someone will simultaneously insisting the city is not touching down. i don't want to live with the uncertainties of hep c. or wonder whether i should seek treatment. i am ready. because today there's harvoni. a revolutionary treatment for the most common type of chronic hepatitis c. harvoni is proven to cure up to 99% of patients... ...who've had no pr

keycorp is responding fairly well. the analyst did not change his price target.ttle in the nasdaq. abigail: yahoo! shares are trading lower in the premarket. tolyst robert peck is moving the sidelines. he has concerns around a core asset sale process. 10% it couldk up come at a handsome profit. the stock could rise by more than 15%. --ent pharmaceuticals shares will be purchased for $736 million in cash. it will expand the company's international footprint. is also higher in the premarket today after ceo elon musk recently tweeted that he hopes to reveal part of the tesla master plan later this week. let's head to europe with mark barton. mark: stocks here are rising for a third consecutive day. the stoxx 600 is up. every single industry group is rising. big news breaking just a few moments ago. burberry is shaking up its management. christopher bailey will stay on as chief creative officer. but the chief executive of a french fashion house will take over as ceo. there has been a lot of pressure on bailey. he has been doing this dual role since may 2014. he will